Related Experiment Video
Updated: Aug 6, 2026

09:44
Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers
Published on: July 7, 2023
Engineering a gluconate bypass carbon entry architecture for robust stationary phase biomanufacturing
Utsuki Yano1, Payel Sarkar2, Michael D Lynch2
1Department of Chemistry, Duke University, Durham, North Carolina, USA.
Metabolic Engineering
|July 24, 2026
Summary
Pyruvate accumulation inhibits stationary phase bioproduction. A novel gluconate-bypass (GBP) metabolic architecture in E. coli overcomes this, enabling sustained glucose uptake and record L-alanine production.
Area of Science:
- Metabolic Engineering
- Synthetic Biology
- Biotechnology
Background:
- Two-stage bioprocesses decouple cell growth from product synthesis for efficient biomanufacturing.
- High production in stationary phase cultures often leads to metabolic decline.
- Pyruvate accumulation in E. coli inhibits stationary-phase glucose uptake.
Purpose of the Study:
- To engineer a metabolic architecture that sustains stationary phase productivity.
- To decouple glucose uptake from pyruvate-mediated inhibition.
- To enhance NADPH cofactor regeneration for biosynthesis.
Main Methods:
- Designed and implemented a gluconate-bypass (GBP) metabolic architecture in E. coli.
- Rerouted carbon flux around glucose-6-phosphate.
- Validated the GBP architecture using NADPH-dependent L-alanine production.
Main Results:
- The GBP architecture enabled prolonged stationary phase productivity by decoupling glucose uptake from pyruvate inhibition.
- Glucose oxidation via GBP intrinsically co-generated NADPH for biosynthetic pathways.
- Achieved a record L-alanine titer of 197 g/L with a 1.6-fold increase in production longevity.
- Resulted in an improved production yield of 94%.
Conclusions:
- The GBP metabolism supports robust stationary phase biosynthesis.
- This metabolic framework is versatile for efficient production of pyruvate-derived chemicals.
- GBP offers a solution to metabolic decline in high-flux bioproduction systems.
Related Concept Videos
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Batch vs Continuous Culture
Fermentation is a foundational biotechnological process used to produce pharmaceuticals, biofuels, enzymes, and food additives. Among industrial strategies, batch and continuous fermentation are the two most widely applied. Although both rely on microbial conversion of substrates into desired products, they differ markedly in operation, productivity, and suitability for specific applications.Batch fermentation occurs in a closed system in which nutrient media and inoculum are added at the...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...

